SEC Form 4 · accession 0001127602-17-009213
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 3:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2017 | S | 100 | $87.825 | D | 386,672 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.835 | D | 386,572 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.87 | D | 386,472 | D | |
| Common Stock | Feb 28, 2017 | S | 21 | $87.895 | D | 386,451 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.90 | D | 386,351 | D | |
| Common Stock | Feb 28, 2017 | S | 245 | $87.91 | D | 386,106 | D | |
| Common Stock | Feb 28, 2017 | S | 155 | $87.92 | D | 385,951 | D | |
| Common Stock | Feb 28, 2017 | S | 301 | $87.93 | D | 385,650 | D | |
| Common Stock | Feb 28, 2017 | S | 250 | $87.94 | D | 385,400 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.975 | D | 385,300 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.99 | D | 385,000 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $88.00 | D | 384,700 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.01 | D | 384,600 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.055 | D | 384,500 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $88.06 | D | 384,200 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.075 | D | 384,100 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.12 | D | 384,000 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.125 | D | 383,900 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.14 | D | 383,800 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $88.19 | D | 383,600 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.20 | D | 383,500 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.235 | D | 383,400 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.24 | D | 383,300 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.25 | D | 383,200 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.26 | D | 383,100 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.365 | D | 383,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.